HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sami Aboumatar Selected Research

Drug Hypersensitivity Syndrome

1/2020Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sami Aboumatar Research Topics

Disease

7Seizures (Absence Seizure)
01/2023 - 01/2020
4Epilepsy (Aura)
01/2023 - 01/2021
1Drug Hypersensitivity Syndrome
01/2020

Drug/Important Bio-Agent (IBA)

6CenobamateIBA
10/2022 - 01/2020
2perampanelIBA
01/2022 - 01/2021
1eslicarbazepine acetateIBA
01/2023

Therapy/Procedure

1Therapeutics
01/2023